Petr V Nazarov
Overview
Explore the profile of Petr V Nazarov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DUonnolo G, Isci D, Nosirov B, Kuppens A, Wantz M, Nazarov P, et al.
Comput Biol Med
. 2024 Oct;
182:109197.
PMID: 39353298
Chemokines and their receptors form a complex interaction network, crucial for precise leukocyte positioning and trafficking. In cancer, they promote malignant cell proliferation and survival but are also critical for...
2.
Scafidi A, Lind-Holm Mogensen F, Campus E, Pailas A, Neumann K, Legrave N, et al.
Heliyon
. 2024 Sep;
10(18):e37792.
PMID: 39315158
Background: Epidemiological studies suggest that metformin reduces the risk of developing several types of cancer, including gliomas, and improves the overall survival in cancer patients. Nevertheless, while the effect of...
3.
Chepeleva M, Kaoma T, Zinovyev A, Toth R, Nazarov P
Bioinform Adv
. 2024 Jul;
4(1):vbae102.
PMID: 39027644
Motivation: Deciphering molecular signals from omics data helps understanding cellular processes and disease progression. Effective algorithms for extracting these signals are essential, with a strong emphasis on robustness and reproducibility....
4.
Lind-Holm Mogensen F, Sousa C, Ameli C, Badanjak K, Pereira S, Muller A, et al.
J Neuroinflammation
. 2024 Jul;
21(1):174.
PMID: 39014482
Background: Specific microglia responses are thought to contribute to the development and progression of neurodegenerative diseases, including Parkinson's disease (PD). However, the phenotypic acquisition of microglial cells and their role...
5.
Yabo Y, Moreno-Sanchez P, Pires-Afonso Y, Kaoma T, Nosirov B, Scafidi A, et al.
Genome Med
. 2024 Apr;
16(1):51.
PMID: 38566128
Background: A major contributing factor to glioblastoma (GBM) development and progression is its ability to evade the immune system by creating an immune-suppressive environment, where GBM-associated myeloid cells, including resident...
6.
Despotovic V, Kim S, Hau A, Kakoichankava A, Klamminger G, Borgmann F, et al.
Heliyon
. 2024 Apr;
10(5):e27515.
PMID: 38562501
We provide in this paper a comprehensive comparison of various transfer learning strategies and deep learning architectures for computer-aided classification of adult-type diffuse gliomas. We evaluate the generalizability of out-of-domain...
7.
Merz M, Seal S, Grova N, Meriaux S, Guebels P, Kanli G, et al.
Sci Rep
. 2024 Mar;
14(1):5898.
PMID: 38467724
Early-life adversity covers a range of physical, social and environmental stressors. Acute viral infections in early life are a major source of such adversity and have been associated with a...
8.
Turner M, Radzikowska U, Ferastraoaru D, Pascal M, Wesseling P, McCraw A, et al.
Allergy
. 2024 Jan;
79(6):1419-1439.
PMID: 38263898
Epidemiological studies have explored the relationship between allergic diseases and cancer risk or prognosis in AllergoOncology. Some studies suggest an inverse association, but uncertainties remain, including in IgE-mediated diseases and...
9.
Rigg E, Wang J, Xue Z, Lunavat T, Liu G, Hoang T, et al.
J Extracell Vesicles
. 2023 Sep;
12(10):e12363.
PMID: 37759347
Melanoma has the highest propensity of all cancers to metastasize to the brain with a large percentage of late-stage patients developing metastases in the central nervous system (CNS). It is...
10.
Randic T, Magni S, Philippidou D, Margue C, Grzyb K, Preis J, et al.
Cell Rep
. 2023 Jun;
42(7):112696.
PMID: 37379213
Treatment options for patients with NRAS-mutant melanoma are limited and lack an efficient targeted drug combination that significantly increases overall and progression-free survival. In addition, targeted therapy success is hampered...